Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
EJNMMI Research
|
December 14, 2021
Detection of the sentinel lymph node with hybrid tracer (ICG-[<sup>99m</sup>Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study
Nuria Sánchez-Izquierdo, Sergi Vidal-Sicart, Francisco Campos, et al.
Journal of Gynecologic Oncology
|
April 28, 2021
Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)
Martina Aida Angeles, Federico Migliorelli, Sergi Vidal-Sicart, et al.
Cancers
|
March 6, 2021
Oncological Results of Laparoscopically Assisted Radical Vaginal Hysterectomy in Early-Stage Cervical Cancer: Should We Really Abandon Minimally Invasive Surgery?
Aureli Torné, Jaume Pahisa, Jaume Ordi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Andrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Oncotargets and Therapy
|
November 25, 2014
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Antonio Gutierrez, Jose Rodriguez, Jordi Martinez-Serra, et al.
World Journal of Clinical Oncology
|
December 15, 2021
Pathological response to neoadjuvant therapy with chemotherapy <i>vs</i> chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
Diego Muñoz-Guglielmetti, David Sanchez-Lorente, Roxana Reyes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study
Stefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
European Radiology
|
September 29, 2021
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [<sup>18</sup>F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125
Ariel Glickman, Pilar Paredes, Núria Carreras-Diéguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2022
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
Joan Carles, Teresa Alonso-Gordoa, Begoña Mellado, et al.
Diagnostics (Basel, Switzerland)
|
July 29, 2025
PET/CT Volumetric Parameters as Predictors of the Peritoneal Cancer Index in Advanced Ovarian Cancer Patients
Ariel Glickman, Blanca Gil-Ibáñez, Aida Niñerola-Baizán, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
EJNMMI Research
|
December 14, 2021
Detection of the sentinel lymph node with hybrid tracer (ICG-[<sup>99m</sup>Tc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study
Nuria Sánchez-Izquierdo, Sergi Vidal-Sicart, Francisco Campos, et al.
Journal of Gynecologic Oncology
|
April 28, 2021
Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)
Martina Aida Angeles, Federico Migliorelli, Sergi Vidal-Sicart, et al.
Cancers
|
March 6, 2021
Oncological Results of Laparoscopically Assisted Radical Vaginal Hysterectomy in Early-Stage Cervical Cancer: Should We Really Abandon Minimally Invasive Surgery?
Aureli Torné, Jaume Pahisa, Jaume Ordi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Andrei Iagaru, Jose F Suarez, Spencer Behr, et al.
Oncotargets and Therapy
|
November 25, 2014
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Antonio Gutierrez, Jose Rodriguez, Jordi Martinez-Serra, et al.
World Journal of Clinical Oncology
|
December 15, 2021
Pathological response to neoadjuvant therapy with chemotherapy <i>vs</i> chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
Diego Muñoz-Guglielmetti, David Sanchez-Lorente, Roxana Reyes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study
Stefano Fanti, Javier Jesus Robles Barba, Spencer Behr, et al.
European Radiology
|
September 29, 2021
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [<sup>18</sup>F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125
Ariel Glickman, Pilar Paredes, Núria Carreras-Diéguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2022
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial
Joan Carles, Teresa Alonso-Gordoa, Begoña Mellado, et al.
Diagnostics (Basel, Switzerland)
|
July 29, 2025
PET/CT Volumetric Parameters as Predictors of the Peritoneal Cancer Index in Advanced Ovarian Cancer Patients
Ariel Glickman, Blanca Gil-Ibáñez, Aida Niñerola-Baizán, et al.
Page
of 5